|
- The group usually releases upbeat results with huge surprise rates.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
|
Sector Generic Pharmaceuticals |
|
| | 1st jan. | Capitalisation (M$) | Investor Rating |
 |
 | MPH HEALTH CARE AG | -2.63% | 115 | - |
|
| |
|
Sales 2020 |
17,5 M
21,2 M
21,2 M
|
Net income 2020 |
-22,0 M
-26,7 M
-26,7 M
|
Net Debt 2020 |
-
-
-
|
P/E ratio 2020 |
-4,35x |
Yield 2020 |
9,01% |
|
Capitalization |
95,0 M
115 M
115 M
|
Capi. / Sales 2020 |
5,43x |
Capi. / Sales 2021 |
2,52x |
Nbr of Employees |
424 |
Free-Float |
100% |
|
Notations Surperformance©
Fundamental ratings
|
Overall rating |
Trading Rating |
- |
Investor Rating |
- |
Growth (Revenue) |
- |
Valuation |
- |
Finances |
- |
Profitability |
- |
Earnings quality |
|
Business Predictability |
- |
P/E ratio |
- |
Potential |
|
Yield |
- |
Consensus |
- |
7 days EPS revision |
- |
4 months EPS revision |
- |
1 year EPS revision |
- |
4 months Revenue revision |
- |
1 year Revenue revision |
- |
|